ARCHIVES

Rich Left AMC “For Personal Reasons”

This article is from The Cancer Letter archive.

Vol. 15 No. 16 | April 21, 1989

Download PDF Visit The Full Archive

Related Articles

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014

New Compounds To Treat Gleevec-Resistant CML

January 26, 2007

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012

Appropriators Ask What Happens After NIH Budget-Doubling Ends In FY2004.

May 25, 2001

Wider Use Of Adjuvant Chemotherapy Recommended By NIH Consensus Panel.

November 10, 2000

In Brief: It’s Finally Official: DRCCA Name Changed To DCPC, Old DCCP Is Div. Of Cancer Etiology

December 9, 1983